Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.98M | 6.44M | 1.22M | 3.31M | 435.00K |
Gross Profit | 5.73M | 2.55M | -396.00K | 457.00K | 138.00K |
EBITDA | -38.06M | -18.87M | -34.91M | -22.35M | -21.00M |
Net Income | -41.94M | -20.03M | -39.62M | -23.87M | -19.99M |
Balance Sheet | |||||
Total Assets | 34.55M | 39.09M | 18.75M | 15.48M | 18.88M |
Cash, Cash Equivalents and Short-Term Investments | 240.00K | 266.00K | 89.00K | 178.00K | 1.01M |
Total Debt | 5.67M | 4.88M | 6.68M | 4.32M | 3.41M |
Total Liabilities | 34.13M | 33.56M | 21.79M | 24.90M | 18.95M |
Stockholders Equity | 425.00K | 5.53M | -3.04M | -9.42M | -63.00K |
Cash Flow | |||||
Free Cash Flow | -9.24M | -18.43M | -15.26M | -16.51M | -12.39M |
Operating Cash Flow | -9.22M | -18.39M | -14.63M | -16.46M | -10.94M |
Investing Cash Flow | 11.00K | -1.11M | -633.00K | 244.00K | -1.39M |
Financing Cash Flow | 9.24M | 19.67M | 15.17M | 15.38M | 13.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
55 Neutral | $51.27M | -1.73 | 271.75% | ― | -44.05% | -2.33% | |
50 Neutral | $69.21M | -8.31 | -53.68% | ― | -42.77% | 83.21% | |
49 Neutral | $23.22M | ― | 128.13% | ― | 32.23% | ― | |
45 Neutral | $17.90M | -31.55 | -12.42% | ― | 485.62% | 85.02% | |
44 Neutral | $50.47M | ― | -936.03% | ― | ― | ― | |
44 Neutral | $84.91M | -2.28 | 20.87% | ― | 28.31% | -239.16% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On September 3, 2025, Mobix Labs, Inc. announced a warrant exercise inducement agreement with a holder of existing warrants, resulting in the exercise of warrants to purchase 5,486,467 shares of common stock, generating approximately $4.5 million in gross proceeds. The company will issue new warrants for 8,229,701 shares, exercisable upon stockholder approval, with Roth Capital Partners acting as financial advisor. The transaction is expected to close on September 4, 2025, and the proceeds will be used for working capital and general corporate purposes.
The most recent analyst rating on (MOBX) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Mobix Labs stock, see the MOBX Stock Forecast page.